Diagnostics of cystic fibrosis in adults

Česká verze

Authors: Libor Fila ¹; Alžběta Grandcourtová ¹; prim. MUDr. Lucie Valentová Bartáková ¹; Zuzana Antušová ²; Eva Pokojová ³; Vladimír Herout ³; Petr Jakubec ⁴; Radka Bittenglová ⁵; Miloslav Marel ¹
Authors place of work: Pneumologická klinika 2. LF UK a FN v Motole, Praha ¹; Plicní klinika LF UK a FN Hradec Králové ²; Klinika nemocí plicních a tuberkulózy LF a FN Brno, pracoviště Bohunice ³; Klinika plicních nemocí a tuberkulózy LF UP a FN Olomouc ⁴; Klinika pneumologie a ftizeologie LF UK a FN Plzeň ⁵
Published in the journal: Vnitř Lék 2016; 62(5): 360-364
Category: Původní práce

Práce byla přednesena na XIX. Kongresu České a Slovenské pneumologické a ftizeologické společnosti v Brně 17.–19. 6. 2015.

Summary

Introduction:
There is an increasing number of cystic fibrosis (CF) patients with the diagnosis established in adulthood worldwide.

Aim:
To give an overview of our experience with the diagnostics of CF in adulthood in the Czech Republic.

Methods:
CF patients with the diagnosis determined at the age ≥ 18 years during 2000–2014 period were selected from the Czech Registry of CF (www.cfregistr.cz). Demographic and clinical data were reported from medical records at the time of diagnosis and as of 31^st December 2014. Only those with two CF causing mutation or with one CF causing mutation together with sweat chloride concentration > 60 mmol/l were included in the study. The clinical presentation was compared with a control group consisting of homozygous F508del patients with the diagnosis established in childhood.

Results:
23 patients (16 men and 7 women) with the diagnosis determined at a mean age of 32.9 ± 8.5 years were included in the study. Presenting symptoms included bronchiectasis and/or haemoptysis in 12 cases, obstructive azoospermia in 7 cases and recurrent pancreatitis in 4 cases. When compared with the control group, the patients had higher age (38.6 ± 8.3 vs. 28.3 ± 4.7 years; p < 0.001), a lower concentration of sweat chloride (62 ± 23 vs. 90 ± 12 mmol/l; p < 0.001), less frequent airway infections with Pseudomonas aeruginosa and/or Burkholderia cepacia complex (4 vs. 12; p = 0.029), bronchiectasis (14 vs. 23; p = 0.001), exocrine pancreatic insufficiency (1 vs. 23; p < 0.001) and therapy with insulin (1 vs. 9; p = 0.01); on the contrary, pancreatitis was more frequent (6 vs. 0; p = 0.022).

Conclusion:
Diagnosis of CF in adults should be considered in those with corresponding symptoms in respiratory, digestive and reproductive tract. Clinical presentation differs from classical CF in many parameters.

Key words:
adults – cystic fibrosis – diagnostics

Zdroje

1. Houštěk J, Vávrová V. Frequency and forms of mucoviscidosis in Czechoslovakia. Cesk Pediatr 1965; 20(3–5): 412–414.

2. Balaščáková M, Holubová A, Skalická V et al. Pilot newborn screening project for cystic fibrosis in the Czech Republic: defining role of the delay in its symptomatic diagnosis and influence of ultrasound-based prenatal diagnosis on the incidence of the disease. J Cyst Fibros 2009; 8(3): 224–227.

3. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 1998; 132(4): 589–595.

4. Cystic Fibrosis Foundation Patient Registry. 2014 Annual Data Report. Bethesda (Maryland). Dostupné z WWW: <https://www.cff.org/2014_CFF_Annual_Data_Report_to_the_Center_Directors.pdf/>. [31.10.2015].

5. Český registr cystické fibrózy. Dostupné z WWW: <https://www.cfregistr.cz/index.php?akce=statistika>. [31.10.2015].

6. Chen H, Ruan YC, Xu WM et al. Regulation of male fertility by CFTR and implications in male infertility. Hum Reprod Update 2012; 18(6): 703–713. Erratum in Hum Reprod Update 2012; 18(6): 715.

7. Boyle MP. Nonclassic cystic fibrosis and CFTR-related diseases. Curr Opin Pulm Med 2003; 9(6): 498–503.

8. Bombieri C, Claustres M, De Boeck K et al. Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros 2011; 10:(Suppl 2): S86-S102.

9. Informace dostupné z WWW: <http://www.cysticfibrosis.org.uk/media/1596846/RegistryReport2014.pdf> [31.10.2015].

10. De Boeck K, Derichs N, Fajac I et al. [ECFS Diagnostic Network Working Group; EuroCareCF WP3 Group on CF diagnosis]. New clinical diagnostic procedures for cystic fibrosis in Europe. J Cyst Fibros 2011; 10(Suppl 2): S53-S66.

11. De Boeck K, Wilschanski M, Castellani C et al. Diagnostic Working Group. Cystic fibrosis: terminology and diagnostic algorithms. Thorax 2006; 61(7): 627–635.

12. Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. N Engl J Med 2005; 352(19): 1992–2001.

13. Burgel PR, Fajac I, Hubert D et al. Non-classic cystic fibrosis associated with D1152H CFTR mutation. Clin Genet 2010; 77(4): 355–364.

14. Terlizzi V, Carnovale V, Castaldo G et al. Clinical expression of patients with the D1152H CFTR mutation. J Cyst Fibros 2015; 14(4): 447–452.

15. Castellani C, Cuppens H, Macek M Jr et al. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros 2008; 7(3): 179–196.

16. Noone PG, Pue CA, Zhou Z et al. Lung disease associated with the IVS8 5T allele of the CFTR gene. Am J Respir Crit Care Med 2000; 162(5): 1919–1924.

17. Peckham D, Conway SP, Morton A et al. Delayed diagnosis of cystic fibrosis associated with R117H on a background of 7T polythymidine tract at intron 8. J Cyst Fibros 2006; 5(1): 63–65.

18. Dítě P, Trna J, Novotný I et al. Chronická pankreatitida v roce 2011. Vnitř Lék 2011; 57(11): 891–966.

19. de Gracia J, Alvarez A, Mata F et al. Cystic fibrosis in adults: study of 111 patients. Med Clin (Barc) 2002; 119(16): 605–609.

20. Rodman DM, Polis JM, Heltshe SL et al. Late diagnosis defines a unique population of long-term survivors of cystic fibrosis. Am J Respir Crit Care Med 2005; 171(6): 621–626.

21. Gilljam M, Ellis L, Corey M et al. Clinical manifestations of cystic fibrosis among patients with diagnosis in adulthood. Chest 2004; 126(4): 1215–1224.